You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
The deals with Stratose, USA Managed Care Organization, and Evolutions Health Systems provides covered access to the test to more than 21 million patients.
NIH researchers have uncovered a blood-based microRNA signature that may be able to tell which patients with precursor disease may progress to myeloma.
The partners will run several studies to validate the use of the MyPRS test in informing disease management in patients with multiple myeloma and its precursors.
As part of the Myeloma XI trial, a UK-led team used exome sequencing on 463 individuals with myeloma to look for mutations related to survival patterns.
The company's revenues fell as test orders from its primary customer dropped 22 percent, a trend it said is expected to continue.
In PNAS this week: optical mapping study of multiple myeloma, role for miR-204 in form of retinal dystrophy, and more.
By combining optical mapping with DNA sequencing, University of Wisconsin-Madison researchers examined structural variation that occurs in multiple myeloma tumors.
The partners will compare Adaptive Bio's clonoSeq MRD test with flow cytometry for accuracy and reliability in monitoring MRD in multiple myeloma patients.
The firm also said it had a net loss of $7.9 million, or $3.50 per share, in 2014, compared to a net loss of $2.4 million, or $12.23 per share, in 2013.
The gift will go toward the creation of theBartBarlogieCenterfor Molecular Diagnostics and the Celgene Distinguished Endowed Chair for Molecular Therapeutics.
Nobel laureates and scientific societies urge NIH and the Department of Health and Human Services to revisit the recent decision to end funding for a coronavirus grant.
Bloomberg reports that BGI's SARS-CoV-2 testing sites in the Middle East have raised concerns among US officials.
A new Pew Research Center poll finds confidence in medical researchers has grown among US adults since the start of the coronavirus pandemic.
In Science this week: machine learning algorithm for faster Mendelian disorder diagnoses, gene linked to safe response to nitrogen-containing bisphosphonates, and more.